Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HUM
HUM logo

HUM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
174.210
Open
167.610
VWAP
171.57
Vol
1.47M
Mkt Cap
20.82B
Low
167.110
Amount
251.88M
EV/EBITDA(TTM)
6.66
Total Shares
120.05M
EV
28.18B
EV/OCF(TTM)
30.60
P/S(TTM)
0.15
Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Show More

Events Timeline

(ET)
2026-03-26
14:10:00
U.S. Justice Department Sues New York-Presbyterian Hospital for Antitrust Violations
select
link
2026-03-03 (ET)
2026-03-03
11:50:00
Humana Partners with Multiple Organizations to Improve Heart Health
select
2026-02-12 (ET)
2026-02-12
16:20:00
Dow Jones Falls 669.42 Points, Nasdaq Drops 469.32 Points
select
2026-02-12
12:20:00
Dow Jones Index Falls 1.10% Amid Technology Profit Concerns
select

News

Newsfilter
9.5
03-30Newsfilter
PinnedHumana to Release Q1 2026 Financial Results
  • Earnings Release Schedule: Humana Inc. will release its Q1 2026 financial results at 6:00 a.m. Eastern Time on April 29, 2026, along with prepared management remarks in PDF format, which is expected to significantly impact investor sentiment.
  • Interactive Q&A Session: The company will host a live Q&A session at 8:00 a.m. Eastern Time on the same day, allowing investors to register in advance, thereby enhancing engagement with management and increasing transparency.
  • Non-GAAP Financial Metrics: The earnings report will include financial measures that are not in accordance with Generally Accepted Accounting Principles (GAAP), providing reconciliations to GAAP results, which will help investors better understand the company's financial health.
  • Investor Relations Page: Investors can access the earnings call webcast and historical presentations via Humana's Investor Relations page, ensuring timely information access and transparency, which further strengthens trust between the company and its investors.
seekingalpha
8.0
03-29seekingalpha
Medicare Trust Fund Expected to Deplete by 2040
  • Trust Fund Depletion Risk: The Medicare Hospital Insurance Trust Fund is projected to be depleted by 2040 according to updated projections from the Congressional Budget Office, which would lead to payment cuts to hospitals and providers, initially estimated to be in the low double digits, potentially triggering a ripple effect throughout the healthcare supply chain.
  • Limited Payment Capacity: Once the trust fund reserves are exhausted, Medicare will shift to a pay-as-you-go system, meaning it can only pay what it receives from payroll taxes, which could further reduce hospital margins and limit available services.
  • Inadequate Mitigation Measures: Analysts indicate that while options like increasing the current 2.9% payroll tax rate or cutting spending could mitigate risks, these measures are highly unpopular, and no significant changes are expected until the situation becomes critical, likely leading to increased volatility in the healthcare sector.
  • Congressional Options: Congress has the ability to protect Medicare by raising payroll taxes or adjusting Medicare Advantage payments, but these proposals face significant resistance, particularly the idea of raising the eligibility age, which could impact insurers like UnitedHealthcare (UNH) and Humana (HUM).
seekingalpha
8.0
03-20seekingalpha
Medicare Advantage Plans Under Cost Control Pressure Ahead of 2027 Rates
  • Cost Control Issues: CMS Deputy Administrator Chris Klomp highlighted that Medicare Advantage plans have not effectively controlled costs, adding pressure to the upcoming 2027 reimbursement rate decision, which could impact insurers' profitability.
  • Reimbursement Rate Proposal: The CMS's proposed flat reimbursement rates for MA insurers in January led to declines in managed care stocks, including UnitedHealth (UNH) and Humana (HUM), reflecting market concerns about future profitability amid regulatory changes.
  • UnitedHealth's Response Strategy: As the largest MA insurer, UnitedHealth indicated it might consider benefit reductions in response to the CMS's “disappointing” initial reimbursement rates, showcasing the company's adaptability and strategic planning in the face of policy shifts.
  • Market Choice Risks: Klomp warned that if the CMS acts “too aggressively” on rates, it could lead to plans exiting certain markets, thereby reducing choices for Medicare recipients and exacerbating market uncertainties.
Newsfilter
8.5
03-12Newsfilter
Significant Increase in CGM Usage Among Medicare Advantage Members
  • Increase in CGM Usage: The proportion of Medicare Advantage members with type 2 diabetes using continuous glucose monitors (CGMs) rose from less than 2% in January 2021 to about 16% by December 2023, indicating a significant increase in technology adoption coinciding with expanded Medicare coverage.
  • Impact of Healthcare Visits: In the 2023 study cohort, patients who had an endocrinology visit were over four times more likely to use a CGM, highlighting the critical role of regular medical interactions in facilitating access to advanced diabetes management tools.
  • Challenges for Older Patients: The analysis revealed that older adults and those with fewer healthcare interactions were less likely to utilize CGMs, suggesting a need for targeted outreach to ensure these vulnerable populations receive essential diabetes management support.
  • Future Coverage Plans: By 2026, most individuals with a Humana Medicare Advantage plan will be able to obtain a CGM at no out-of-pocket cost, which is expected to further enhance CGM adoption and improve health outcomes for diabetes management.
NASDAQ.COM
2.0
03-12NASDAQ.COM
U.S. HMO Industry Faces Challenges and Opportunities
  • Rising Medical Costs: U.S. health insurers are experiencing increased medical expenses due to the resumption of deferred care and heightened demand for chronic disease management, leading to a rise in insurance claims and pressure on profit margins.
  • Regulatory Uncertainty: New legislation may tighten Medicaid eligibility and reduce ACA enrollment, impacting insurers' membership and reimbursements, which forces a shift towards commercial insurance products to enhance profitability.
  • Healthcare Workforce Shortage: The ongoing shortage of nurses and healthcare professionals is straining hospital operations, affecting HMOs' ability to deliver high-quality care, which could lead to customer attrition.
  • M&A Strategy: HMO companies are pursuing mergers and acquisitions to expand market share and enhance competitiveness, with expected interest rate declines in 2026 likely to fuel further M&A activity, driving industry consolidation.
seekingalpha
7.0
03-10seekingalpha
Congressional Investigation Reveals Medicare Overpayment Issues
  • Medicare Overpayment Investigation: The Joint Economic Committee's investigation revealed that alleged overpayments to Medicare Advantage plans resulted in a $13.4 billion increase in Medicare Part B premiums last year, primarily impacting seniors, highlighting potential financial pressures within the Medicare system.
  • Premium Hike Impact: The investigation found that the average Medicare premium for American seniors rose by approximately 10%, equating to over $200 annually, directly affecting beneficiaries of both Medicare Advantage and standard Medicare, indicating a pressing need for policy adjustments.
  • Insurer Rebuttal: America's Health Insurance Plans (AHIP), representing health insurers, denied the investigation's findings, claiming they were based on “fundamentally flawed data and methodology,” illustrating the industry's strong opposition to policy changes and potential conflicts of interest.
  • Market Participant Overview: UnitedHealth (UNH) stands as the largest player in the Medicare Advantage market, followed by Humana (HUM) and others, underscoring the significant role and influence of major insurers in the evolving landscape of Medicare policy.
Wall Street analysts forecast HUM stock price to rise
19 Analyst Rating
Wall Street analysts forecast HUM stock price to rise
6 Buy
12 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
231.00
Averages
290.39
High
344.00
Current: 0.000
sliders
Low
231.00
Averages
290.39
High
344.00
Barclays
Equal Weight
downgrade
$245 -> $176
AI Analysis
2026-02-25
Reason
Barclays
Price Target
$245 -> $176
AI Analysis
2026-02-25
downgrade
Equal Weight
Reason
Barclays lowered the firm's price target on Humana to $176 from $245 and keeps an Equal Weight rating on the shares. The firm is 'incrementally cautious" on the company's expectation that Individual Medicare Advantage margins will double.
Wells Fargo
Equal Weight
downgrade
$290 -> $206
2026-02-18
Reason
Wells Fargo
Price Target
$290 -> $206
2026-02-18
downgrade
Equal Weight
Reason
Wells Fargo lowered the firm's price target on Humana to $206 from $290 and keeps an Equal Weight rating on the shares. The firm notes EPS guidance was established at over $9, with key swing factors being underlying margin improvement on retained MA members and underlying profitability of membership growth. Outsized membership growth leaves a wide range outcomes in Wells' view.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HUM
Unlock Now

Valuation Metrics

The current forward P/E ratio for Humana Inc (HUM.N) is 19.64, compared to its 5-year average forward P/E of 18.59. For a more detailed relative valuation and DCF analysis to assess Humana Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
18.59
Current PE
19.64
Overvalued PE
20.87
Undervalued PE
16.32

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
11.86
Current EV/EBITDA
11.44
Overvalued EV/EBITDA
13.43
Undervalued EV/EBITDA
10.28

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.48
Current PS
0.23
Overvalued PS
0.64
Undervalued PS
0.31

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stock bearish today
Intellectia · 57 candidates
Market Cap: >= 2.00BPrice Change Pct: <= $-3.00Moving Average Relationship: PriceBelowMA20, PriceBelowMA200
Ticker
Name
Market Cap$
top bottom
BMI logo
BMI
Badger Meter Inc
4.89B
CVNA logo
CVNA
Carvana Co
104.69B
APH logo
APH
Amphenol Corp
198.88B
TLK logo
TLK
Telkom Indonesia (Persero) Tbk PT
23.13B
LPL logo
LPL
LG Display Co Ltd
4.36B
VFC logo
VFC
VF Corp
7.85B
stocks bearish for a week
Intellectia · 82 candidates
Price: >= $5.00Moving Average Relationship: PriceBelowMA20Week Price Change Pct: <= $-7.00Month Price Change Pct: <= $-10.00Monthly Average Dollar Volume: >= 800,000
Ticker
Name
Market Cap$
top bottom
VENU logo
VENU
Venu Holding Corp
364.84M
RGNX logo
RGNX
Regenxbio Inc
698.09M
NNNN logo
NNNN
Anbio Biotechnology
2.89B
HUM logo
HUM
Humana Inc
25.28B
CVLT logo
CVLT
Commvault Systems Inc
4.05B
SMX logo
SMX
SMX (Security Matters) PLC
156.97M
find me stock that have found their bottom
Intellectia · 25 candidates
Weekly Average Turnover: >= 1,000,000Rsi 14: <= 70Moving Average Relationship: PriceCrossAboveMA20Support Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B
stocks with wolfe wave buy signals
Intellectia · 43 candidates
Relative Vol: >= 0.800Rsi 14: 40 - 70Moving Average Relationship: PriceAboveMA20Candlestick Pattern: WhiteCandlestickSupport Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B
suche andere Möglichkeiten bzw. Aktien
Intellectia · 25 candidates
Beta: LowRiskAnalyst Action: UpgradeTarget Price Upside Potential: AbovePriceMonth Price Change Pct: >= $5.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
CVX logo
CVX
Chevron Corp
335.71B
MRK logo
MRK
Merck & Co Inc
275.78B
TMO logo
TMO
Thermo Fisher Scientific Inc
239.06B
BA logo
BA
Boeing Co
190.08B
HON logo
HON
Honeywell International Inc
139.15B
GD logo
GD
General Dynamics Corp
98.53B
show me stocks with a bullish reversal
Intellectia · 131 candidates
Relative Vol: >= 1.20Rsi 14: 30 - 60Moving Average Relationship: PriceCrossAboveMA20Candlestick Pattern: WhiteCandlestickMonth Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
GOOG logo
GOOG
Alphabet Inc
3.96T
LLY logo
LLY
Eli Lilly and Co
1.02T
SCHW logo
SCHW
Charles Schwab Corp
180.87B
BTI logo
BTI
British American Tobacco plc
125.29B
ARM logo
ARM
Arm Holdings PLC
120.87B
COP logo
COP
ConocoPhillips
120.05B

Whales Holding HUM

P
Pacific Investment Management Company LLC
Holding
HUM
+20.89%
3M Return
M
Maple Rock Capital Partners Inc.
Holding
HUM
+20.32%
3M Return
T
Tontine Management, LLC
Holding
HUM
+18.02%
3M Return
S
Slate Path Capital LP
Holding
HUM
+13.83%
3M Return
H
Hartford Funds Management Company, LLC
Holding
HUM
+3.39%
3M Return
H
Hotchkis and Wiley Capital Management, LLC
Holding
HUM
+1.51%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Humana Inc (HUM) stock price today?

The current price of HUM is 173.39 USD — it has increased 4.45

What is Humana Inc (HUM)'s business?

Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.

What is the price predicton of HUM Stock?

Wall Street analysts forecast HUM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUM is290.39 USD with a low forecast of 231.00 USD and a high forecast of 344.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Humana Inc (HUM)'s revenue for the last quarter?

Humana Inc revenue for the last quarter amounts to 32.52B USD, increased 11.30

What is Humana Inc (HUM)'s earnings per share (EPS) for the last quarter?

Humana Inc. EPS for the last quarter amounts to -6.61 USD, increased 14.96

How many employees does Humana Inc (HUM). have?

Humana Inc (HUM) has 67060 emplpoyees as of April 01 2026.

What is Humana Inc (HUM) market cap?

Today HUM has the market capitalization of 20.82B USD.